AbbVie Balance Sheet Health
Financial Health criteria checks 3/6
AbbVie has a total shareholder equity of $6.1B and total debt of $71.3B, which brings its debt-to-equity ratio to 1174.8%. Its total assets and total liabilities are $143.4B and $137.4B respectively. AbbVie's EBIT is $17.3B making its interest coverage ratio 9. It has cash and short-term investments of $7.3B.
Key information
1,174.8%
Debt to equity ratio
US$71.32b
Debt
| Interest coverage ratio | 9x |
| Cash | US$7.29b |
| Equity | US$6.07b |
| Total liabilities | US$137.35b |
| Total assets | US$143.42b |
Recent financial health updates
Recent updates
Betting Big On AbbVie: A Prescription For Growth And Dividends
Dec 11AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.64
Dec 09
AbbVie: Upgrading To 'Strong Buy' After Pullback
Nov 22AbbVie's (NYSE:ABBV) Dividend Will Be Increased To $1.64
Nov 19AbbVie's (NYSE:ABBV) Soft Earnings Are Actually Better Than They Appear
Nov 12AbbVie Stock: Keep Calm And Buy The Dip
Nov 11AbbVie: 3 Positives From The Earnings Report
Oct 30AbbVie: Strong Dividends But Humira Disappoints
Oct 22AbbVie: Dividend Discount Model Suggests Large Valuation Risks
Sep 29We Think AbbVie (NYSE:ABBV) Can Stay On Top Of Its Debt
Sep 06Why AbbVie Remains One Of My Favorite Dividend Growers
Aug 27AbbVie: Growth Is Still A Better Choice
Jul 29AbbVie Q2 2024 Earnings Preview: Post Gonzalez Era Can Begin On Positive Note
Jul 17AbbVie: A Hold Again (Rating Downgrade)
Jul 03Earnings Tell The Story For AbbVie Inc. (NYSE:ABBV)
Jun 28AbbVie: 5 Reasons That Make A Buy Case
Jun 18Financial Position Analysis
Short Term Liabilities: ABBV's short term assets ($27.8B) do not cover its short term liabilities ($43.1B).
Long Term Liabilities: ABBV's short term assets ($27.8B) do not cover its long term liabilities ($94.3B).
Debt to Equity History and Analysis
Debt Level: ABBV's net debt to equity ratio (1054.8%) is considered high.
Reducing Debt: ABBV had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: ABBV's debt is well covered by operating cash flow (23.1%).
Interest Coverage: ABBV's interest payments on its debt are well covered by EBIT (9x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 08:28 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AbbVie Inc. is covered by 54 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Luisa Hector | Berenberg |